RENAISSANCE TECHNOLOGIES LLC

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in NTLA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$23,688,067

+$8,650,494 QoQ

Shares Held

1,400,004

-16.3% QoQ

Ownership

0.999%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#23

of 330 holders

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. NTLA ranks #31 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,688,067	1,400,004	-16.3%	Shares	Sole	2026-08-13
2025-12-31	$15,037,573	1,672,700	+156.9%	Shares	Sole	2026-02-12
2025-09-30	$11,242,770	651,000	-3.8%	Shares	Sole	2025-11-13
2025-06-30	$6,349,322	676,900	+585.8%	Shares	Sole	2025-08-13
2024-12-31	$1,150,842	98,700	+155.0%	Shares	Sole	2025-02-13
2024-06-30	$866,106	38,700	+188.9%	Shares	Sole	2024-08-09
2023-12-31	$408,474	13,397	-19.1%	Shares	Sole	2024-02-13
2023-03-31	$616,967	16,554	-86.2%	Shares	Sole	2023-05-12
2022-06-30	$6,190,496	119,600	+191.7%	Shares	Sole	2022-08-12
2020-06-30	$861,820	41,000	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.